CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Shares withheld for taxes | −704 | $278.03 | $196K | 42,805 |
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Shares withheld for taxes | −622 | $278.03 | $173K | 42,183 |
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Shares withheld for taxes | −607 | $278.03 | $169K | 41,576 |
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Option exercise · Restricted Stock Unit | −1,586 | 1,788 | ||
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Other disposition · Restricted Stock Unit | −1,788 | 0 | ||
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Other disposition · Restricted Stock Unit | −1,936 | 4,746 | ||
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Option exercise · Restricted Stock Unit | −1,402 | 3,344 | ||
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Other disposition · Restricted Stock Unit | −1,849 | 7,801 | ||
| 2021-02-12 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Option exercise · Restricted Stock Unit | −1,367 | 6,434 | ||
| 2021-02-09 | Mantas Jesus B Director | Purchase | +898 | $267.00 | $240K | 2,943 |
| 2021-01-27 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Grant or award | +4,545 | 41,117 | ||
| 2021-01-27 | Galdes Alphonse EVP Pharmaceutical Oper & Tech | Grant or award | +818 | 3,445.23 | ||
| 2021-01-27 | Gregory Ginger EVP, Human Resources | Grant or award | +2,558 | 7,249.36 | ||
| 2021-01-27 | Sandrock Alfred EVP, Research & Development | Grant or award | +3,728 | 16,794.21 | ||
| 2021-01-27 | Vounatsos Michel Chief Executive Officer | Grant or award | +16,343 | 51,153.29 | ||
| 2020-12-03 | Kramer Robin VP, Chief Accounting Officer | Option exercise | +74 | 395.45 | ||
| 2020-12-03 | Kramer Robin VP, Chief Accounting Officer | Shares withheld for taxes | −22 | $244.09 | $5K | 373.45 |
| 2020-12-03 | Kramer Robin VP, Chief Accounting Officer | Option exercise · Restricted Stock Unit | −74 | 280 | ||
| 2020-12-03 | Kramer Robin VP, Chief Accounting Officer | Other disposition · Restricted Stock Unit | −102 | 178 | ||
| 2020-12-01 | Guindo Chirfi EVP Glob. Prod Strat and Comm | Shares withheld for taxes | −348 | $243.16 | $85K | 3,523 |
Page 40 of 45 · 886 trades